Suresh K. Durgam - Mar 2, 2022 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Chief Medical Officer
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Stock symbol
ITCI
Transactions as of
Mar 2, 2022
Transactions value $
-$452,313
Form type
4
Date filed
3/4/2022, 05:05 PM
Previous filing
Feb 25, 2022
Next filing
Mar 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Sale -$238K -4.18K -13.41% $56.98 27K Mar 2, 2022 Direct F1
transaction ITCI Common Stock Sale -$214K -3.86K -14.32% $55.52 23.1K Mar 4, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2021.